Intel’s had a challenging year or two, at least as far as its best processors are concerned. With things like the Raptor Lake instability issues and the less-than-impressive generational ...

Cabozantinib, an oral tyrosine kinase inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of patients with previously treated advanced neuroendocrine ...

The FDA approved cabozantinib (Cabometyx) for advanced neuroendocrine cancers. Cabozantinib was investigated in both pancreatic and extrapancreatic neuroendocrine tumors. The phase 3 CABINET trial ...

Hundreds of the most advanced, experienced, and passionate search marketers on the planet are heading to Boston June 11-13 for the ultimate in-person return of SMX Advanced. This is your chance to ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Stocks recently featured in the blog include: NVIDIA Corp. NVDA, Microsoft Corp. MSFT, Alphabet Inc. GOOGL, Intel Corp. INTC and Advanced Micro Devices, Inc. AMD. Here are highlights from Tuesday ...